SCHEMBL8280206

SCHEMBL8280206

CCc1ccc(-c2ccccc2CN)cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 3/20 0.50
▸ PRMT5 O14744 1/20 0.44
▸ WDR77 Q9BQA1 1/20 0.44
▸ TRPA1 O75762 1/20 0.41
▸ NOS3 P29474 1/20 0.41
▸ NOS1 P29475 1/20 0.41
▸ NOS2 P35228 1/20 0.41
▸ ALOX5AP P20292 1/20 0.39
▸ FEN1 P39748 1/20 0.39
▸ F10 P00742 2/20 0.37
▸ PTGS1 P23219 1/20 0.36
▸ PTGS2 P35354 1/20 0.36
▸ ATR Q13535 1/20 0.35
▸ GRM5 P41594 1/20 0.35
▸ CSNK2A2 P19784 1/20 0.35
▸ CSNK2B P67870 1/20 0.35
▸ CSNK2A1 P68400 1/20 0.35
▸ CSNK2A3 Q8NEV1 1/20 0.35
▸ CCNT1 O60563 1/20 0.34
▸ CCNA2 P20248 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21116042 0.81 TRPA1 (0.37) TRPA1ALOX5APFEN1PTGS1PTGS2
SCHEMBL8279412 0.80 DPP4 (0.53) DPP4PRMT5WDR77TRPA1NOS3
SCHEMBL30607577 0.79 DPP4 (0.49) DPP4NOS3NOS1NOS2
SCHEMBL31359602 0.78 HPGD (0.45) ALOX5APFEN1PTGS1PTGS2GRM5
SCHEMBL14007487 0.76 DPP4 (0.49) DPP4LOXL2
SCHEMBL30332418 0.75 DPP4 (0.47) DPP4TRPA1NOS3NOS1NOS2
SCHEMBL26040044 0.74 PRMT5 (0.46) PRMT5WDR77PTGS1PTGS2
SCHEMBL10271458 0.73 RAB9A (0.45) PRMT5WDR77
SCHEMBL16814937 0.73 DPP4 (0.49) DPP4NOS3NOS1NOS2
SCHEMBL9498645 0.73 LMNA (0.38) PRMT5WDR77TRPA1PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005090354-A1 PYRAZOLO[3,4-b] PYRIDINE COMPOUNDS, AND THEIR USE AS PDE4 INHIBITORS GLAXO GROUP LIMITED (GB) 2005-09-29 — — WO disclosed
Send feedback